VA to run trial of GLP-1 drug to treat alcohol abuse The Department of Veterans Affairs on Thursday announced a clinical trial to test whether injectable semaglutide, a GLP-1 drug widely prescribed for diabetes and weight loss can also treat alcohol abuse, a longstanding problem in the military and veteran community
A strategy for risk management of drug-induced phospholipidosis
Warfarin and other anticoagulants in line with GLP-1 RA SmPCs (e.g., semaglutide), more frequent INR monitoring is advisable when starting retatrutide or changing the dose, as any alteration in gastric motility could affect anticoagulant control
Book a Clarity Call and lets talk through what may be driving your symptoms, what labs would be useful, and what next step makes the most sense for you
This transition in the market arises due to the changing approach towards obesity being considered as a chronic disease, with comorbidities such as type 2 diabetes and other diseases